Alliance Medical
Alliance Medical is an independent radiology services company founded in 1989 by Robert Waley-Cohen operating across Europe.
In 2010 Lloyds Bank, Commerzbank and M&G Investments acquired 85% of the company in a debt-for-equity swap.[1]
A consortium, called the Collaborative Network, between the company and Christie Hospital NHS Foundation Trust won a ten-year NHS contract to provide PET-CT scanning services across 30 locations in England in January 2015.[2] provide PET/CT scanning services to 60 percent of the population across 30 locations in England, according to a statement by The Christie. The contract provides for investment of £87 million over 10 years to install new scanners and improve the current infrastructure. Twenty four existing sites will remain where they are, and six new sites will be added at William Harvey Hospital; Cumberland Infirmary; Lincoln County Hospital; Southmead Hospital; Royal United Hospital; and Royal Cornwall Hospital. [3]
In 2013 the company acquired IBA Molecular UK and Erigal, two of the three companies in England that produce the radioactive isotope Fludeoxyglucose (18F), which is injected into patients as part of the imaging process. Siemens Healthcare is the only other UK producer. [4]
References
- ↑ "Lloyds-led debt-for-equity swap on Alliance Medical brings more woe for DIC". Daily Telegraph. 11 December 2010. Retrieved 22 February 2015.
- ↑ "Alliance Medical-led consortium wins PET-CT contract". Health Investor. 29 January 2015. Retrieved 22 February 2015.
- ↑ "Alliance Medical led consortium wins PET/CT contract from NHS England". Dot Med. 12 February 2015. Retrieved 22 February 2015.
- ↑ "'Monopoly' fears over £350m scans contract". Local Government Chronicle. 12 February 2015. Retrieved 22 February 2015.